Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools
Authors
Keywords
-
Journal
BIOTECHNOLOGY LETTERS
Volume 42, Issue 3, Pages 403-418
Publisher
Springer Science and Business Media LLC
Online
2020-01-08
DOI
10.1007/s10529-020-02792-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
- (2018) Karin Hoppe-Seyler et al. TRENDS IN MICROBIOLOGY
- Human papilloma virus: global research architecture assessed by density-equalizing mapping
- (2018) Dörthe Brüggmann et al. Oncotarget
- Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers
- (2018) Stephanie Dorta-Estremera et al. CANCER RESEARCH
- A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins
- (2018) Heidar Ali Panahi et al. PLoS One
- Prediction of cross-clade HIV-1 T-cell epitopes using immunoinformatics analysis
- (2018) Niloofar Khairkhah et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Nanoparticle conjugation of human papillomavirus 16 E7-long peptides enhances therapeutic vaccine efficacy against solid tumors in mice
- (2018) Gabriele Galliverti et al. Cancer Immunology Research
- Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
- (2018) Basit Jabbar et al. Frontiers in Immunology
- The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
- (2018) Miren Taberna et al. Frontiers in Oncology
- NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
- (2017) Vanessa Jurtz et al. JOURNAL OF IMMUNOLOGY
- Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism
- (2017) Patricia M. Day et al. JOURNAL OF VIROLOGY
- Simultaneous refinement of inaccurate local regions and overall structure in the CASP12 protein model refinement experiment
- (2017) Gyu Rie Lee et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7
- (2017) Kwong Y. Tsang et al. VACCINE
- Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women
- (2017) Ying Liu et al. Scientific Reports
- Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains
- (2016) Krishna P. Singh et al. 3 Biotech
- Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains
- (2016) Krishna P. Singh et al. 3 Biotech
- Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach
- (2015) Anoop Kumar et al. BIOLOGICALS
- The I-TASSER Suite: protein structure and function prediction
- (2015) Jianyi Yang et al. NATURE METHODS
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach
- (2014) Arafat Oany et al. Drug Design Development and Therapy
- Designing of interferon-gamma inducing MHC class-II binders
- (2013) Sandeep Kumar Dhanda et al. Biology Direct
- HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo
- (2013) Shu-jie Liao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Immune responses induced in HHD mice by multiepitope HIV vaccine based on cryptic epitope modification
- (2013) Yinghui Li et al. MOLECULAR BIOLOGY REPORTS
- Recombinant Lipidated HPV E7 Induces a Th-1-Biased Immune Response and Protective Immunity against Cervical Cancer in a Mouse Model
- (2012) Chiung-Yi Huang et al. PLoS One
- Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value
- (2012) Niladri Ganguly CELLULAR ONCOLOGY
- Papillomavirus E5: the smallest oncoprotein with many functions
- (2011) Aldo Venuti et al. Molecular Cancer
- Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies
- (2010) Sheila V Graham Future Microbiology
- Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses
- (2010) Danylo Sirskyj et al. IMMUNOLOGY AND CELL BIOLOGY
- Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines
- (2010) Reinis INTERNATIONAL JOURNAL OF ONCOLOGY
- ElliPro: a new structure-based tool for the prediction of antibody epitopes
- (2008) Julia Ponomarenko et al. BMC BIOINFORMATICS
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
- (2008) John T. Schiller et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started